Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
13F holders, Q4 2025 (December 31)4holders −1
1new positions
2sold out
$0.89avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) in their 13F filings, down 1 from Q3 2025. 1 opened new positions and 2 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($3.1M), State of Wisconsin Investment Board ($2.7M) and New York State Common Retirement Fund ($848K).
- Company
- Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
- CUSIP
- 803607AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $848K |
| Exits | 2 | $4.0M |
All 13F filers, Q3 2025 → Q4 2025: 953,000 shares bought and 5,400,000 shares sold, net −4,447,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Reduce -20.4% | 3,500,000 | $3.1M |
| State of Wisconsin Investment Board | 0.01% | No change | 3,000,000 | $2.7M |
| New York State Common Retirement Fund | 0.00% | New | 953,000 | $848K |
| Rothschild Investment LLC | 0.00% | No change | 1,000 | $890 |
"% of holder's portfolio" is SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27)'s weight in each manager's 13F, not the share of Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) the manager owns.